| Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). IA Ferber, S Brocke, C Taylor-Edwards, W Ridgway, C Dinisco, ... Journal of immunology (Baltimore, Md.: 1950) 156 (1), 5-7, 1996 | 1255 | 1996 |
| Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S Brocke, K Gijbels, M Allegretta, I Ferber, C Piercy, T Blankensteini, ... Nature 379 (6563), 343-346, 1996 | 434 | 1996 |
| Green tea epigallocatechin-3-gallate mediates T cellular NF-κB inhibition and exerts neuroprotection in autoimmune encephalomyelitis O Aktas, T Prozorovski, A Smorodchenko, NE Savaskan, R Lauster, ... The Journal of Immunology 173 (9), 5794-5800, 2004 | 410 | 2004 |
| Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin O Aktas, S Waiczies, A Smorodchenko, J Dörr, B Seeger, T Prozorovski, ... The Journal of experimental medicine 197 (6), 725-733, 2003 | 373 | 2003 |
| Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. S Mendlovic, S Brocke, Y Shoenfeld, M Ben-Bassat, A Meshorer, ... Proceedings of the National Academy of Sciences 85 (7), 2260-2264, 1988 | 372 | 1988 |
| Antibodies to CD44 and integrin α4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary … S Brocke, C Piercy, L Steinman, IL Weissman, T Veromaa Proceedings of the National Academy of Sciences 96 (12), 6896-6901, 1999 | 361 | 1999 |
| Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen S Brocke, A Gaur, C Piercy, A Gautam, K Gijbels, CG Fathman, ... Nature 365 (6447), 642-644, 1993 | 337 | 1993 |
| Suppressive vaccination with DNA encoding a variable region gene of the T–cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity A Waisman, PJ Ruiz, DL Hirschberg, A Gelman, JR Oksenberg, S Brocke, ... Nature medicine 2 (8), 899-905, 1996 | 304 | 1996 |
| Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis MK Shaw, JB Lorens, A Dhawan, R DalCanto, HY Tse, AB Tran, ... The Journal of experimental medicine 185 (9), 1711-1714, 1997 | 293 | 1997 |
| Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL O Aktas, A Smorodchenko, S Brocke, C Infante-Duarte, US Topphoff, ... Neuron 46 (3), 421-432, 2005 | 274 | 2005 |
| Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon … N Karin, DJ Mitchell, S Brocke, N Ling, L Steinman The Journal of experimental medicine 180 (6), 2227-2237, 1994 | 268 | 1994 |
| Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. T Brenner, S Brocke, F Szafer, RA Sobel, JF Parkinson, DH Perez, ... Journal of immunology (Baltimore, Md.: 1950) 158 (6), 2940-2946, 1997 | 195 | 1997 |
| Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity … K Gijbels, S Brocke, JS Abrams, L Steinman Molecular Medicine 1, 795-805, 1995 | 176 | 1995 |
| Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-β1 secretion in vivo A Steinbrecher, D Reinhold, L Quigley, A Gado, N Tresser, L Izikson, ... The Journal of Immunology 166 (3), 2041-2048, 2001 | 173 | 2001 |
| Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms A Gaur, SA Boehme, D Chalmers, PD Crowe, A Pahuja, N Ling, S Brocke, ... Journal of neuroimmunology 74 (1-2), 149-158, 1997 | 154 | 1997 |
| In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II … S Brocke, C Brautbar, L Steinman, O Abramsky, J Rothbard, D Neumann, ... The Journal of clinical investigation 82 (6), 1894-1900, 1988 | 144 | 1988 |
| Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice K Beider, A Nagler, O Wald, S Franitza, M Dagan-Berger, H Wald, ... Blood 102 (6), 1951-1958, 2003 | 141 | 2003 |
| Experimental autoimmune encephalomyelitis in IL-4-deficient mice. R Liblau, L Steinman, S Brocke International immunology 9 (5), 799-803, 1997 | 127 | 1997 |
| The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity D Reinhold, T Kähne, A Steinbrecher, S Wrenger, K Neubert, S Ansorge, ... Walter de Gruyter 383 (7-8), 1133-1138, 2002 | 98 | 2002 |
| Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION‐46L enhanced in vivo MRI: early histopathological correlation S Xu, EK Jordan, S Brocke, JWM Bulte, L Quigley, N Tresser, JL Ostuni, ... Journal of neuroscience research 52 (5), 549-558, 1998 | 96 | 1998 |
